MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Cabergoline

Cabergoline 1mg tablets

Incompatible

Stability notes for Cabergoline 1mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light. Original packaging may contain dessicant. No stability data in MCAs available.

Provenance

This recommendation is based on the products Cabaser 1mg tablets (Pfizer Limited) and Cabergoline 1mg (Renata (UK) Limited).

Suppliers (7) of Cabergoline 1mg tablets
Cabaser 1mg tablets (Pfizer Ltd)
Cabergoline 1mg tablets (A A H Pharmaceuticals Ltd)
Cabergoline 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Cabergoline 1mg tablets (Medihealth (Northern) Ltd)
Cabergoline 1mg tablets (Necessity Supplies Ltd)
Cabergoline 1mg tablets (Sigma Pharmaceuticals Plc)
Cabergoline 1mg tablets (Teva UK Ltd)

Cabergoline 2mg tablets

Incompatible

Stability notes for Cabergoline 2mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light. Original packaging may contain dessicant. No stability data in MCAs available.

Provenance

This recommendation is based on the products Cabaser 2mg tablets (Pfizer Limited) and Cabergoline 2mg (Renata (UK) Limited).

Suppliers (5) of Cabergoline 2mg tablets
Cabaser 2mg tablets (Pfizer Ltd)
Cabergoline 2mg tablets (A A H Pharmaceuticals Ltd)
Cabergoline 2mg tablets (Medihealth (Northern) Ltd)
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc)
Cabergoline 2mg tablets (Teva UK Ltd)

Cabergoline 500microgram tablets

Incompatible

Stability notes for Cabergoline 500microgram tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light. Original packaging may contain dessicant. No stability data in MCAs available.

Provenance

This recommendation is based on the products Dostinex 0.5mg tablets (Pfizer Limited) and Cabergoline 0.5mg (Renata (UK) Limited).

Suppliers (15) of Cabergoline 500microgram tablets
Cabergoline 500microgram tablets (A A H Pharmaceuticals Ltd)
Cabergoline 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Cabergoline 500microgram tablets (Aspire Pharma Ltd)
Cabergoline 500microgram tablets (CST Pharma Ltd)
Cabergoline 500microgram tablets (Medihealth (Northern) Ltd)
Cabergoline 500microgram tablets (Milpharm Ltd)
Cabergoline 500microgram tablets (Necessity Supplies Ltd)
Cabergoline 500microgram tablets (Pilsco Ltd)
Cabergoline 500microgram tablets (Sigma Pharmaceuticals Plc)
Cabergoline 500microgram tablets (Teva UK Ltd)
Cabergoline 500microgram tablets (Zentiva Pharma UK Ltd)
Dostinex 500microgram tablets (CST Pharma Ltd)
Dostinex 500microgram tablets (Lexon (UK) Ltd)
Dostinex 500microgram tablets (Necessity Supplies Ltd)
Dostinex 500microgram tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.